Atlas Trials

Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection

Clinical trial NCT06021483 · RECRUITING

Trial details

NCT number
NCT06021483
Sponsor
Boryung Pharmaceutical Co., Ltd
Status
RECRUITING
Study type
OBSERVATIONAL
SCLC
Start date
2023-08-16
Primary completion
2025-09-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.